HOME Top Market Reports Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020

Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: December 2015
Report Code: MD 2349

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global tissue diagnostics market is valued at USD 3,202.5 Million in 2015 and expected to reach USD 4,471.1 Million by 2020 at a CAGR of 6.9% from 2015 to 2020. Tissue-based diagnostic tests are performed for screening, diagnosing, and monitoring the response of cancer patients to therapy. The scope of the tissue diagnostics market includes major technologies like ISH, IHC, digital pathology and workflow, and special staining; and products like instruments and consumables that are used to determine medical information for the diagnosis of diseases or conditions.

The global tissue diagnostics market is segmented into products, technology, diseases, and end users. On the basis of product, the tissue diagnostics market is segmented into instruments and consumables. The instruments product segment is further subsegmented into slide-staining systems, scanners, tissue-processing systems, and other instruments. Other instruments include digital pathology systems, and histology equipment like automated cover slippers, microtomes, paraffin dispensers, and slide labelers. The consumables product segment is further subsegmented into antibodies, kits, reagents, and probes.

On the basis of technology, the market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. On the basis of diseases, the  market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, NSCLC, and other diseases. On the basis of end user, the tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users.

Based on geography the global tissue diagnostics market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).

A major driver for the growth of the tissue diagnostics industry is the increasing prevalence of cancer. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market. However, the high growth potential in emerging economies and the increased use of personalized medicine will provide new growth opportunities to players in the market.

The top leaders in tissue diagnostics market include Abbott Laboratories (U.S.), Agilent Technologies (U.S.), BioGenex Laboratories (U.S.), Bio SB (U.S.), Cell Signaling Technology (U.S.), Danaher Corporation (U.S.), F. Hoffman-La Roche AG (Switzerland), Sigma-Aldrich (U.S.), Thermo Fisher Scientific (U.S.), and Sakura Finetek Japan Co.

Scope of the Report

This research report categorizes the global tissue diagnostics market into the following segments and subsegments:

Tissue diagnostics Market, by Product

  • Instruments
    • Slide-staining systems
    • Scanners
    • Tissue-processing systems
    • Other instruments
  • Consumables
    • Antibodies
    • Kits
    • Reagents
    • Probes

Tissue diagnostics Market, by Technology

  • Immunohistochemistry
  • In situ hybridization
  • Digital pathology and workflows
  • Special staining

Tissue diagnostics Market, by diseases

  • Breast cancer
  • Gastric cancer
  • Lymphoma
  • Prostate cancer
  • NSCLC
  • Other diseases

Tissue diagnostics Market, by End User

  • Hospitals,
  • Pharmaceutical companies
  • Research laboratories
  • Contract research organizations
  • Others end users

Tissue diagnostics Market, by Region

  • Asia
  • Europe
  • North America
  • Rest of the World

Table of Contents

1 Introduction (Page No. - 10)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 13)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Market Share Estimation
           2.3.1 Key Data From Secondary Sources
           2.3.2 Key Data From Primary Sources
           2.3.3 Assumptions for the Study

3 Executive Summary (Page No. - 20)

4 Premium Insights (Page No. - 25)
    4.1 Global Tissues Diagnostics Market Overview
    4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. - 28)
    5.1 Introduction
           5.1.1 By Disease
           5.1.2 By End User
           5.1.3 By Product
           5.1.4 By Technology
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Incidences of Cancer
                    5.2.1.2 Rapidly Increasing Aging Population
                    5.2.1.3 Growing Healthcare Expenditure
           5.2.2 Restraints
                    5.2.2.1 Stringent Regulatory Requirements and Compliance
                    5.2.2.2 High Degree of Consolidation
                    5.2.2.3 Budget Constraints
           5.2.3 Opportunities
                    5.2.3.1 High Growth in Emerging Markets
                    5.2.3.2 Increased Use of Personalized Medicine
           5.2.4 Trends
                    5.2.4.1 Increasing Number of Reagent Rental Agreements

6 Tissue Diagnostics Market, By Product (Page No. - 37)
    6.1 Introduction
    6.2 Consumables
           6.2.1 Antibodies
           6.2.2 Kits
           6.2.3 Reagents
           6.2.4 Probes
    6.3 Instruments
           6.3.1 Slide-Staining Systems
           6.3.2 Scanners
           6.3.3 Tissue-Processing Systems
           6.3.4 Other Instruments

7 Tissue Diagnostics Market, By Diseases (Page No. - 54)
    7.1 Introduction
    7.2 Breast Cancer
    7.3 Gastric Cancer
    7.4 Lymphoma
    7.5 Prostate Cancer
    7.6 Non-Small Cell Lung Cancer
    7.7 Other Diseases

8 Tissue Diagnostics Market, By Technology (Page No. - 67)
    8.1 Introduction
    8.2 Immunohistochemistry (IHC)
    8.3 in Situ Hybridization (ISH)
    8.4 Digital Pathology and Workflow Management
    8.5 Special Staining

9 Tissue Diagnostics Market, By End User (Page No. - 76)
    9.1 Introduction
    9.2 Hospitals
    9.3 Research Laboratories
    9.4 Pharmaceutical Companies
    9.5 Contract Research Organizations
    9.6 Other End Users

10 Tissue Diagnostics Market, By Region (Page No. - 85)
     10.1 Introduction
     10.2 North America
              10.2.1 U.S.
              10.2.2 Canada
     10.3 Europe
     10.4 Asia
     10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. - 120)
     11.1 Introduction
     11.2 Strategic Overview
     11.3 Leading Players in the Tissue Diagnostics Market
     11.4 Competitive Situation and Trends
              11.4.1 New Products Launches and Product Upgrades
              11.4.2 Acquisitions
              11.4.3 Expansions
              11.4.4 Agreements, Collaborations, Contracts, Marketing Initiatives, and Partnerships
              11.4.5 Other Developments

12 Company Profiles (Page No. - 129)
     12.1 Introduction
     12.2 Abbott Laboratories, Inc.
              12.2.1 Business Overview
              12.2.2 Products Offered
              12.2.3 Recent Developments
              12.2.4 MnM View
     12.3 Agilent Technologies, Inc.
              12.3.1 Business Overview
              12.3.2 Products Offered
              12.3.3 Recent Developments
              12.3.4 MnM View
     12.4 Bio Sb
              12.4.1 Business Overview
              12.4.2 Products Offered
              12.4.3 Recent Developments
              12.4.4 MnM View
     12.5 Biogenex Laboratories
              12.5.1 Business Overview
              12.5.2 Products Offered
              12.5.3 Recent Developments
              12.5.4 MnM View
     12.6 Cell Signaling Technology, Inc.
              12.6.1 Business Overview
              12.6.2 Products Offered
              12.6.3 Recent Developments
              12.6.4 MnM View
     12.7 Danaher Corporation
              12.7.1 Business Overview
              12.7.2 Products Offered
              12.7.3 Recent Developments
              12.7.4 MnM View
     12.8 F. Hoffman-La Roche AG
              12.8.1 Business Overview
              12.8.2 Products Offered
              12.8.3 Recent Developments
              12.8.4 MnM View
     12.9 Sakura Finetek Japan Co., Ltd.
              12.9.1 Business Overview
              12.9.2 Products Offered
              12.9.3 Recent Developments
     12.10 Sigma-Aldrich Corporation
              12.10.1 Business Overview
              12.10.2 Products Offered
              12.10.3 Recent Development
              12.10.4 MnM View
     12.11 Thermo Fisher Scientific
              12.11.1 Business Overview
              12.11.2 Products Offered
              12.11.3 Recent Developments
              12.11.4 MnM View

13 Appendix (Page No. - 156)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Other Developments
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports


List of Tables (76 Tables)

Table 1 Tissue Diagnostics Market Summary
Table 2 Rising Incidences of Cancer are the Primary Driver for the Market
Table 3 Stringent Regulatory Requirements is A Key Restraint for the Growth of the Market
Table 4 Emerging Economies Present Significant Growth Opportunities
Table 5 Increasing Number of Reagent Rental Agreements is A Major Trend for the Growth of This Market
Table 6 Market Size, By Product, 20132020 (USD Million)
Table 7 Market Size, By Consumable, 20132020 (USD Million)
Table 8 Market Size for Consumables, By Region, 20132020 (USD Million)
Table 9 Market Size for Antibodies, By Region, 20132020 (USD Million)
Table 10 Market Size for Kits, By Region, 20132020 (USD Million)
Table 11 Market Size for Reagents, By Region, 20132020 (USD Million)
Table 12 Market Size for Probes, By Region, 20132020 (USD Million)
Table 13 Market Size, By Instrument, 20132020 (USD Million)
Table 14 Market Size for Instruments, By Region, 20132020 (USD Million)
Table 15 Market Size for Slide-Staining Systems, By Region, 20132020 (USD Million)
Table 16 Market Size for Scanners, By Region, 20132020 (USD Million)
Table 17 Market Size for Tissue-Processing Systems, By Region, 20132020 (USD Million)
Table 18 Market Size for Other Instruments, By Region, 20132020 (USD Million)
Table 19 Market Size, By Disease, 20132020 (USD Million)
Table 20 Market Size for Breast Cancer, By Region, 20132020 (USD Million)
Table 21 Market Size for Gastric Cancer, By Region, 20132020 (USD Million)
Table 22 Market Size for Lymphoma, By Region, 2013-2020 (USD Million)
Table 23 Market Size for Prostate Cancer, By Region, 20132020 (USD Million)
Table 24 Market Size for Non-Small Cell Lung Cancer, By Region, 20132020 (USD Million)
Table 25 Market Size for Other Diseases, By Region, 20132020 (USD Million)
Table 26 Market Size, By Technology, 20132020 (USD Million)
Table 27 Market Size for Immunohistochemistry, By Region, 20132020 (USD Million)
Table 28 Market Size for in Situ Hybridization, By Region, 20132020 (USD Million)
Table 29 Market Size for Digital Pathology and Workflow Management, By Region, 2013-2020 (USD Million)
Table 30 Market Size for Special Staining, By Region, 20132020 (USD Million)
Table 31 Market Size, By End User, 20132020 (USD Million)
Table 32 Market Size for Hospitals, By Region, 20132020 (USD Million)
Table 33 Market Size for Research Laboratories, By Region, 20132020 (USD Million)
Table 34 Market Size for Pharmaceutical Companies, By Region, 2013-2020 (USD Million)
Table 35 Market Size for Contract Research Organizations, By Region, 20132020 (USD Million)
Table 36 Market Size for Other End Users, By Region, 20132020 (USD Million)
Table 37 Market Size, By Region, 20132020 (USD Million)
Table 38 North America: Market Size, By Country, 20132020 (USD Million)
Table 39 North America: Market Size, By Product, 20132020 (USD Million)
Table 40 North America: Market Size for Consumables, By Type, 20132020 (USD Million)
Table 41 North America: Market Size for Instruments, By Type, 20132020 (USD Million)
Table 42 North America: Market Size, By Disease, 20132020 (USD Million)
Table 43 North America: Market Size, By Technology, 20132020 (USD Million)
Table 44 North America: Market Size, By End User, 20132020 (USD Million)
Table 45 U.S.: Market Size, By Product, 20132020 (USD Million)
Table 46 U.S.: Market Size, By Disease, 20132020 (USD Million)
Table 47 U.S.: Market Size, By Technology, 20132020 (USD Million)
Table 48 U.S.: Market Size, By End User, 20132020 (USD Million)
Table 49 Canada: Market Size, By Product, 20132020 (USD Million)
Table 50 Canada: Market Size, By Disease, 20132020 (USD Million)
Table 51 Canada: Market Size, By Technology, 20132020 (USD Million)
Table 52 Canada: Market Size, By End User, 20132020 (USD Million)
Table 53 Europe: Market Size, By Product, 20132020 (USD Million)
Table 54 Europe: Market Size for Consumables, By Type, 20132020 (USD Million)
Table 55 Europe: Market Size for Instruments, By Type, 20132020 (USD Million)
Table 56 Europe: Market Size, By Disease, 20132020 (USD Million)
Table 57 Europe: Market Size, By Technology, 20132020 (USD Million)
Table 58 Europe: Market Size, By End User, 20132020 (USD Million)
Table 59 Asia: Market Size, By Product, 20132020 (USD Million)
Table 60 Asia: Market Size for Consumables, By Type, 20132020 (USD Million)
Table 61 Asia: Market Size for Instruments, By Type, 20132020 (USD Million)
Table 62 Asia: Market Size, By Disease, 20132020 (USD Million)
Table 63 Asia: Market Size, By Technology, 20132020 (USD Million)
Table 64 Asia: Market Size, By End User, 20132020 (USD Million)
Table 65 RoW: Market Size, By Product, 20132020 (USD Million)
Table 66 RoW: Market Size for Consumables, By Type, 20132020 (USD Million)
Table 67 RoW: Tissue Diagnostics Market Size for Instruments, By Type, 20132020 (USD Million)
Table 68 RoW: Tissue Diagnostics Market Size, By Disease, 20132020 (USD Million)
Table 69 RoW: Tissue Diagnostics Market Size, By Technology, 20132020 (USD Million)
Table 70 RoW: Tissue Diagnostics Market Size, By End User, 20132020 (USD Million)
Table 71 Market Developments Between 2012 and 2015
Table 72 New Product Launches and Product Upgrades, 20122015
Table 73 Acquisitions, 20122015
Table 74 Expansions, 20122015
Table 75 Agreements, Collaborations, Contracts, Marketing Initiatives, and Partnerships, 20122015
Table 76 Other Developments, 20122015
 

List of Figures (96 Figures)

Figure 1 Global Tissue Diagnostics Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Tissue Diagnostics Market Size, By Product, 2015 vs. 2020 (USD Million)
Figure 8 Tissue Diagnostics Market Size, By Technology, 2015 vs. 2020 (USD Million)
Figure 9 Tissue Diagnostics Market Size, By Disease, 2015 vs. 2020 (USD Million)
Figure 10 Tissue Diagnostics Market Size, By End User, 2015 vs. 2020 (USD Million)
Figure 11 Tissue Diagnostics Market Size, By Region, 2015 vs. 2020 (USD Million)
Figure 12 Rising Incidences of Cancer to Drive Market Growth
Figure 13 Immunohistochemistry Segment to Account for the Largest Market Share in 2015
Figure 14 Asia to Witness Highest Growth Rate in the Forecast Period (2015 to 2020)
Figure 15 Asia Holds Lucrative Growth Opportunities
Figure 16 Tissue Diagnostics Market Segmentation: By Disease
Figure 17 Tissue Diagnostics Market Segmentation: By End User
Figure 18 Tissue Diagnostics Market Segmentation: By Product
Figure 19 Tissue Diagnostics Market Segmentation: By Technology
Figure 20 Increasing Incidences of Cancer are Expected to Drive the Tissue Diagnostics Market During the Forecast Period
Figure 21 Increasing Healthcare Expenditure Will Drive the Tissue Diagnostics Market
Figure 22 Rapid Growth in Healthcare Expenditure in Emerging Markets is an Important Growth Opportunity
Figure 23 Tissue Diagnostics Market, By Product
Figure 24 Tissue Diagnostics Market Size, By Product, 2015 (USD Million)
Figure 25 Tissue Diagnostics Market Size, By Consumables, 2015 (USD Million)
Figure 26 North America to Command the Largest Share of the Consumables Product Segment in 2015
Figure 27 North America to Command the Largest Share of the Antibodies Product Segment in 2015
Figure 28 North America to Command the Largest Share of the Kits Product Segment in 2015
Figure 29 North America to Command the Largest Share of the Reagents Product Segment in 2015
Figure 30 North America to Command the Largest Share of the Probes Product Segment in 2015
Figure 31 Tissue Diagnostics Market Size, By Instrument, 2015 (USD Million)
Figure 32 North America to Command the Largest Share of the Instruments Product Segment in 2015
Figure 33 North America to Command the Largest Share of the Slide-Staining Systems Product Segment in 2015
Figure 34 North America to Command the Largest Share of the Scanners Product Segment in 2015
Figure 35 North America to Command the Largest Share of the Tissue-Processing Systems Product Segment in 2015
Figure 36 North America to Command the Largest Share of the Other Instruments Product Segment in 2015
Figure 37 Tissue Diagnostics Market, By Disease
Figure 38 Tissue Diagnostics Market Size, By Disease, 2015 (USD Million)
Figure 39 North America to Command the Largest Share of the Breast Cancer Disease Segment in 2015
Figure 40 Asia to Be the Fastest-Growing Segment in the Tissue Diagnostics Market for Gastric Cancer in 2015
Figure 41 Asia to Witness Highest Growth in the Lymphoma Disease Segment in 2015
Figure 42 North America to Command the Largest Share of the Prostate Cancer Disease Segment in 2015
Figure 43 North America to Command the Largest Share of the Non-Small Cell Lung Cancer Disease Segment in 2015
Figure 44 Asia to Be the Fastest-Growing Market in the Other Diseases Segment in 2015
Figure 45 Tissue Diagnostics Market Segmentation, By Technology
Figure 46 Tissue Diagnostics Market Size, By Technology, 2015 (USD Million)
Figure 47 North America to Dominate the Immunohistochemistry Technology Segment in 2015
Figure 48 Asia to Be the Fastest-Growing Market in the in Situ Hybridization  Technology Segment in 2015
Figure 49 Asia to Witness Highest Growth in the Digital Pathology and Workflow Management Technology Segment in 2015
Figure 50 North America to Dominate the Special Staining Technology Segment in 2015
Figure 51 Tissue Diagnostics Market Segmentation, By End User
Figure 52 Tissue Diagnostics Market Size, By End User, 2015 (USD Million)
Figure 53 North America to Dominate the Hospital End-User Segment in 2015
Figure 54 The  Research Laboratories End-User Segment in Asia to Witness the Highest Growth in the Forecast Period
Figure 55 Pharmaceutical Companies Segment in Asia to Witness Highest Growth in the Forecast Period
Figure 56 North America to Dominate the Contract Research Organizations End-User Segment in 2015
Figure 57 North America to Dominate the Other End-Users Segment in 2015
Figure 58 Tissue Diagnostics Market Segmentation, By Region
Figure 59 North America to Dominate the Global Tissue Diagnostics Market in the Forecast Period
Figure 60 Tissue Diagnostics Market in Asia to Witness the Highest Growth From 2015 to 2020
Figure 61 North America: Market Snapshot
Figure 62 U.S. is Expected to Be the Fastest-Growing Market in North America in 2015
Figure 63 Consumables to Command the Largest Share of the Tissue Diagnostics Market in North America During the Forecast Period
Figure 64 Antibodies to Dominate the Tissue Diagnostics Market for Consumables in North America During the Forecast Period
Figure 65 Slide Staining Systems to Dominate the Tissue Diagnostics Market for Consumables in North America During the Forecast Period
Figure 66 Breast Cancer to Form the Largest Disease Segment in North America in 2015
Figure 67 Immunohistochemistry to Form the Largest Technology Segment in North America in 2015
Figure 68 Hospitals to Form the Largest End-User Segment in North America in 2015
Figure 69 Consumables to Command the Largest Share of the Tissue Diagnostics Market in Europe During the Forecast Period
Figure 70 Antibodies to Dominate the Tissue Diagnostics Market for Consumables in Europe During the Forecast Period
Figure 71 Slide Staining Systems to Dominate the Tissue Diagnostics Market for Instruments in Europe During the Forecast Period
Figure 72 Breast Cancer to Form the Largest Disease Segment in Europe in 2015
Figure 73 Immunohistochemistry to Form the Largest Technology Segment in Europe in 2015
Figure 74 Hospitals to Form the Largest End-User Segment in Europe in 2015
Figure 75 Asia: Market Snapshot
Figure 76 Consumables to Command the Largest Share of the Tissue Diagnostics Market in Asia During the Forecast Period
Figure 77 Antibodies to Dominate the Tissue Diagnostics Market for Consumables in Asia During the Forecast Period
Figure 78 Slide Staining Systems to Dominate the Tissue Diagnostics Market for Instruments in Asia During the Forecast Period
Figure 79 Breast Cancer to Form the Largest Disease Segment in Asia in 2015
Figure 80 Immunohistochemistry to Form the Largest Technology Segment in Asia in 2015
Figure 81 Hospitals to Form the Largest End-User Segment in Asia in 2015
Figure 82 Consumables Command the Largest Share of the Tissue Diagnostics Market in RoW During the Forecast Period
Figure 83 Antibodies to Dominate the Tissue Diagnostics Market for Consumables in RoW During the Forecast Period Between 20152020
Figure 84 Slide Staining Systems to Dominate the Tissue Diagnostics Market for Instruments in RoW During the Forecast Period Between 20152020
Figure 85 Breast Cancer to Form the Largest Disease Segment in RoW in 2015
Figure 86 Immunohistochemistry to Form the Largest Technology Segment in RoW in 2015
Figure 87 Hospitals to Form the Largest End-User Segment in RoW in 2015
Figure 88 Key Developments in the Tissue Diagnostics Market, 2010-2015
Figure 89 Tissue Diagnostics Market Share Analysis, By Key Player, 2015
Figure 90 Snapshot of the Financial Performances of the Leading Market Players
Figure 91 Abbott Laboratories, Inc.: Company Snapshot
Figure 92 Agilent Technologies, Inc.: Company Snapshot
Figure 93 Danaher Corporation: Company Snapshot
Figure 94 F. Hoffman-La Roche AG: Company Snapshot
Figure 95 Sigma-Aldrich Corporation: Company Snapshot
Figure 96 Thermo Fisher Scientific: Company Snapshot

The global tissue diagnostics market is valued at USD 3,202.5 Million in 2015 and expected to reach USD 4,471.1 Million by 2020, at a CAGR of 6.9% from 2015 to 2020. A major driver for the growth of the tissue diagnostics industry is the increasing prevalence of cancer. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market. However, the high growth potential in emerging economies and the increased use of personalized medicine will provide new growth opportunities to players in the market.

This report segments the global market based on product, technology, disease, and end user. On the basis of product, the market is segmented into instruments and consumables. In 2015, consumables are expected to account for the largest share of the global market, by product, due to their low cost and ease of use.

On the basis of technology, the tissue diagnostics market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. In 2015, the immunohistochemistry segment is expected to account for the largest share of the global market. The technology is mainly driven by growth in the IVD (in vitro diagnostics) market.

On the basis of diseases, the tissue diagnostics market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, NSCLC, and other diseases. In 2015, the breast cancer segment is expected to account for the largest share of the global market. The growth of this segment is driven by the increasing incidence of breast cancer.

On the basis of end user, the tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users. In 2015, the hospitals segment is expected to account for the largest share of the global market. This large share is attributed to the easy accessibility and availability of test results in hospitals in a shorter period of time.

On the basis of region, the tissue diagnostics market is segmented into Asia, Europe, North America, and the Rest of the World (RoW). In 2015, North America is expected to command the largest share of the global market.

The major players in tissue diagnostics market include Abbott Laboratories (U.S.), Agilent Technologies (U.S.), BioGenex Laboratories (U.S.), Bio SB (U.S.), Cell Signaling Technology (U.S.), Danaher Corporation (U.S.), F. Hoffman-La Roche AG (Switzerland), Sigma-Aldrich (U.S.), Thermo Fisher Scientific (U.S.), and Sakura Finetek Japan Co.

Tissue Diagnostics Market

Tissue Diagnostics Market

Tissue Diagnostics Market

Tissue Diagnostics Market

Tissue Diagnostics Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports